Biosimilars
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Biosimilars | Breaking News
Samsung Bioepis, C-Bridge Capital to Develop Next-Gen Biosims in China
C-Bridge forms new biopharmaceutical company, AffaMed Therapeutics, which will collaborate with Samsung Bioepis02.11.19
-
Bio News | Biosimilars | Breaking News | Industry News
Alvotech Raises $300M to Fuel Biosimilar Growth
Current pipeline consists of six biosimilar monoclonal antibodies aimed at treating cancer, autoimmune, inflammatory and other diseases01.22.19
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Sandoz Enters Biosimilars Deal with Gan & Lee Pharmaceutical in China
Covers biosimilar insulins in early and clinical development for the top three selling branded insulins by sales: glargine, lispro and aspart12.28.18
-
Biosimilars | Breaking News | Drug Development | Industry News
Alvotech, Fuji Pharma Expand Biosimilars Alliance
Fuji invests $50 million in Alvotech, expands development and commercialization of biosimilars in Japan12.18.18
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Alvotech and Fuji Pharma Enter Biosimilars Tie-up
Partnership gives Fuji Pharma a leading position in the Japanese biosimilar market11.20.18
-
Biosimilars
Biosimilar Market Trends
2017 was a record year for biosimilar approvals.Fiona Greer and Bruno Speder, SGS 09.11.18
-
Biologics, Proteins, Vaccines | Biosimilars | Drug Development
Haste Makes Waste
When to sprint and when to breathe in the race from lab to clinic.Christian Cattaruzza, MilliporeSigma 09.11.18
-
Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | cGMP Manufacture | Industry News
REPORT: Biopharma Mfg. Capacity and Production
222 biopharma companies surveyed plus130 industry vendors and direct suppliers of materials08.17.18
-
Biosimilars
Navigating Uncertainty in Biosimilar Drug Development
Bryan Katz of Syneos Health and Brittany Scott of Addison Whitney share insights from DIABryan Katz, Vice President Integrated Solutions, Syneos Health and Brittany Scott, Creative Director, Addison Whitney, a Syneos Health company 07.11.18
-
Bio News | Biosimilars | Collaborations & Alliances | Drug Development | Industry News
Prestige BioPharma, Alvogen Enter Agreement
For the exclusive partnership and supply for the commercialization of Prestige BioPharma´s Trastuzumab biosimilar in Europe07.02.18
-
Bio News | Biosimilars | Breaking News | Industry News
Oncobiologics Enters First CDMO Contract
Officially launches BioSymphony Platform-based CDMO business06.18.18
-
Bio News | Biosimilars | Drug Development | Industry News
SGS Continues to Lead in Comparability Services
Business development manager Nicole Kovacs shares insight on SGS life sciences division's servicesVideos
-
Biologics, Proteins, Vaccines | Biosimilars
Biogenerics Progress
Generic makers target big forays into major marketsS. Harachand, Contributing Editor 06.12.18
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Beactica Signs Three-Year Extension Agreement With Sanofi
Results from the collaboration contributed towards approval of Insulin lispro06.01.18
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
mAbxience, Amneal Enter Biosimilar Tie-up
Agreement will bring a biosimilar of bevacizumab to the U.S.05.23.18
-
Bio News | Biosimilars | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Catalent, Valerius Enter Biosimilars Collaboration
Catalent Biologics to provide cell line development and support cGMP manufacturing05.14.18
-
Biologics, Proteins, Vaccines | Biosimilars
Biopharma Manufacturing Markets
Biomanufacturing contract services and supplies markets continue to expandRonald A. Rader and Eric S. Langer, BioPlan Associates 05.08.18
-
Bio News | Biosimilars
Know the Challenges of Biosimilar Manufacturing
Best Practices for a Competitive MarketJerry Martin, Pharmaceutical and Life Sciences Consultant to PMMI, and, Dr. Michiel Ultee, Principal, Ulteemit BioConsulting, LLC 04.11.18
-
Biologics, Proteins, Vaccines | Biosimilars
Contract BioManufacturing in China: Creating a New Segment
An up-close look at China’s growing market for CMO services.Vicky Qing Xia and Leo Cai Yang, BioPlan Associates 04.10.18
-
Biosimilars | Drug Development
Differentiating in the Biosimilar Market: Surviving the Cost of Entry
Companies need to improve customer experience, produce additional evidence, and create valuable engagement with stakeholdersMichael Turner and Magnus Franzen, Life Sciences Experts, PA Consulting Group 03.01.18
